Care Access is a healthcare organization dedicated to enhancing global health by facilitating access to medical resources and promoting participation in clinical research. The company operates over 200 research sites worldwide, supported by a team of hundreds of traveling clinicians and a fleet of more than 150 mobile health clinics. This extensive network enables Care Access to deliver healthcare and research services directly to communities in need.
Company Overview
- Headquarters: 33 Arch Street, 17th Floor, Boston, Massachusetts, 02110, United States
- Founded: 2016
- CEO: Ahmad Namvargolian
- Employees: Approximately 884
- Annual Revenue: Estimated at $175.4 million
Mission and Services
Care Access aims to make a significant impact on individuals' lives and improve the health of future generations. The organization assists people in understanding their health, accessing necessary health resources, and participating in research to discover new medicines and cures. By integrating healthcare staff with centralized research operations and technology, Care Access strives to make clinical trials a viable care option for every patient.
Leadership Team
The leadership team at Care Access comprises seasoned professionals from various industries, collaborating to address challenges in clinical trial delivery. Key members include:
- Dr. Sinikka Green, MD: Medical Director, Principal Investigator
- Dr. Irving Loh, MD: Scientific Advisor, Cardiology
- Dr. Christine Thai, MD: Medical Advisor, Principal Investigator
- Dr. Peta-Gay Jackson Booth, MD: Director, Principal Investigator
- Dr. Anthony Eaton, MD: Director, Principal Investigator
- Dr. Chandar Abboy, MD: Director, Principal Investigator
- Dr. Luis Russo, MD: CEO, Care Access Brasil
- Dr. Gigi Lefebvre, MD: Director, Principal Investigator
- Dr. Ali Bajwa, MD: Director, Principal Investigator
These leaders bring extensive experience from institutions such as Emory University School of Medicine, the National Heart, Lung, and Blood Institute at NIH, and Howard University.
Market Position and Industry Context
Care Access operates within the rapidly growing patient access solutions market. This market was valued at approximately $1.9 billion in 2022 and is projected to reach $2.9 billion by 2027, growing at a compound annual growth rate (CAGR) of 8.9%. Factors driving this growth include the need to maintain regulatory compliance, the rising importance of denials management, and the increasing adoption of healthcare IT solutions.
In North America, the connected care industry is also experiencing significant expansion. By the end of 2023, there were 33.3 million individuals utilizing connected care services, with projections indicating growth to 57.2 million users by 2028. This growth is driven by the aging population and the increasing prevalence of chronic diseases, highlighting the importance of efficient healthcare delivery systems like those provided by Care Access.
Competitive Landscape
Care Access faces competition from several companies in the healthcare and clinical research sectors, including:
- Science 37: Specializes in decentralized clinical trials.
- PCM Trials: Provides mobile research services.
- Medical Research Network: Offers home trial support services.
These competitors focus on various aspects of clinical research and patient access solutions, contributing to the dynamic nature of the industry.
Recent Developments
Care Access has been actively expanding its reach and capabilities through strategic partnerships and acquisitions:
- Acquisition of IBPClin (June 2022): Care Access acquired IBPClin, a leading clinical trial center in Rio de Janeiro, enhancing its presence in South America.
- Partnership with Eli Lilly (September 2021): Collaborated to broaden patient access to clinical trials and increase representation of minority groups.
- Collaboration with AstraZeneca (January 2021): Worked together to accelerate a clinical trial in the U.S. for AstraZeneca’s long-acting monoclonal antibody combination for potential COVID-19 prevention.
